NEUPOGEN

Verified summary

FILGRASTIM, SOLUTION INJECTABLE, 30 MUI, 1 BOITE 1 SERINGUE

Common uses

Decreasing the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs,Reducing the time to neutrophil recovery and the duration of fever following induction or consolidation chemotherapy in patients with acute myeloid leukemia (AML),Reducing the duration of neutropenia and neutropenia-related clinical sequelae in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT),Mobilizing autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis,Reducing the incidence and duration of sequelae of severe neutropenia in symptomatic patients with congenital, cyclic, or idiopathic neutropenia,Increasing survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)

Class

leukocyte growth factor

Availability note

Reimbursable